Fund code: 299

  • NAV
    $59.08 $0.16 / 0.27%
    29-Mar-2023
  • Inception 05-Jun-1997
  • Benchmark MSCI AC World Health Care Index
  • Aggregate assets
    (all series)
    $264.2M
    28-Feb-2023
  • MER 2.24%
    30-Sep-2022
  • Distributions
  • Morningstar category Sector Equity
  • Also available through: Trust US$ and Class CDN$
  • Get Fund Facts

End investment

Annualized return

Choose a chart type (percentage or dollar)
Choose a predefined chart period
to:

Start NAV

$10.0000

End NAV

$10.4031
Choose a predefined chart period
to:

Calendar returns (%) 28-Feb-2023

YTD 2023 2022 2021 2020 2019 2018 2017 2016
Fund -3.10 -7.74 19.22 9.18 18.30 13.84 10.92 -15.18

Standard period returns (%) 28-Feb-2023

1 mo 3 mo 6 mo 1 yr 3 yr 5 yr 10 yr Inception
Fund -1.59 -4.63 4.97 -1.43 6.93 8.75 11.89 7.19

Why invest in this fund?

  • Offers exposure to dynamic growth opportunities across the global health care sector.
  • Leverages Fidelity’s expertise in managing industry-specific funds.

Risk measures (%) 28-Feb-2023

Fund
Annualized standard deviation 13.36
Beta 1.01
0.90

Risk classification

  1. Low
  2. Low to medium
  3. Medium
  4. Medium to high
  5. High

This fund has a medium volatility rating

Allocation

Asset mix (%)

31-Jan-2023

Country mix (%)

31-Jan-2023

Sector mix (%)

31-Jan-2023
12 months ago Last month Current month
Pharma Products 23.8 31.1 29.1
Life Sciences Tools & Services 30.9 19.9 21.7
Health Care Equipment & Supplies 18.0 16.1 18.0
Health Care Providers & Services 15.1 20.0 17.0
Biotech. 6.5 8.0 7.9

Top ten holdings

  1. UnitedHealth Group
  2. Johnson & Johnson
  3. Thermo Fisher Scientific
  4. ROCHE HLDGS AG (GENUSSCHEINE)
  5. AstraZeneca
  6. AbbVie
  7. Elevance Health
  8. Danaher
  9. Stryker
  10. Bristol-Myers Squibb
Total number of holdings 44
Top ten holdings aggregate 52.5%
  1. UnitedHealth Group
  2. ROCHE HLDGS AG (GENUSSCHEINE)
  3. Thermo Fisher Scientific
  4. Johnson & Johnson
  5. Danaher
  6. Elevance Health
  7. Bristol-Myers Squibb
  8. AstraZeneca
  9. AbbVie
  10. Stryker
Total number of holdings 47
Top ten holdings aggregate 53.4%
  1. UnitedHealth Group
  2. Thermo Fisher Scientific
  3. AstraZeneca
  4. Bristol-Myers Squibb
  5. ICON plc
  6. AbbVie
  7. ROCHE HLDGS AG (GENUSSCHEINE)
  8. Danaher
  9. IQVIA
  10. Elevance Health
Total number of holdings 50
Top ten holdings aggregate 53.2%
  1. UnitedHealth Group
  2. Thermo Fisher Scientific
  3. ROCHE HLDGS AG (GENUSSCHEINE)
  4. Danaher
  5. AstraZeneca
  6. ICON plc
  7. Stryker
  8. Sonova Holding
  9. IQVIA
  10. Bristol-Myers Squibb
Total number of holdings 50
Top ten holdings aggregate 51.3%
View all